Download PDF
CC BY-NC-ND 4.0 · Avicenna J Med 2016; 06(03): 65-68
DOI: 10.4103/2231-0770.184062
REVIEW ARTICLE

Critical congenital heart disease screening

Mohammed A Chamsi-Pasha
Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA
,
Hassan Chamsi-Pasha
Division of Cardiovascular Medicine, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Critical congenital heart disease (CCHD) is a heart lesion for which neonates require early surgical intervention to survive. Without intervention, the rates of mortality and survival with significant disability are extremely high. Early diagnosis can potentially improve health outcomes in newborns with CCHD. Until recent years, no routine screening protocol existed. In the last few years, pulse oximetry screening for CCHD in newborns has been added to the list of recommended uniform screening panels and advocated by several health-care authorities. A positive screening test result warrants an echocardiogram to evaluate for CCHD. Newborn screens do not usually require parental consent. However, most of the states mandates in the United States include a statement allowing exemption from the screen on the basis of parental religious or personal beliefs.

Keywords

Critical congenital heart disease - pulse oximetry - screening


Publication History

Article published online:
09 August 2021

© 2016. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Olney RS, Ailes EC, Sontag MK. Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening. Semin Perinatol 2015;39:230-7.
  • 2 Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 2010;122:2254-63.
  • 3 Holland BJ, Myers JA, Woods CR Jr. Prenatal diagnosis of critical congenital heart disease reduces risk of death from cardiovascular compromise prior to planned neonatal cardiac surgery: A meta-analysis. Ultrasound Obstet Gynecol 2015;45:631-8.
  • 4 Ailes EC, Gilboa SM, Riehle-Colarusso T, Johnson CY, Hobbs CA, Correa A, et al. Prenatal diagnosis of nonsyndromic congenital heart defects. Prenat Diagn 2014;34:214-22.
  • 5 Amsbaugh S, Scott SD, Foss K. Pulse oximetry screening for critical congenital heart disease: Bringing evidence into practice. J Pediatr Nurs 2015;30:591-7.
  • 6 Mahle WT, Martin GR, Beekman RH 3 rd , Morrow WR; Section on Cardiology and Cardiac Surgery Executive Committee. Endorsement of health and human services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 2012;129:190-2.
  • 7 Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, Thangaratinam S, et al. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): A test accuracy study. Lancet 2011;378:785-94.
  • 8 Thangaratinam S, Brown K, Zamora J, Khan KS, Ewer AK. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: A systematic review and meta-analysis. Lancet 2012;379:2459-64.
  • 9 de-Wahl Granelli A, Wennergren M, Sandberg K, Mellander M, Bejlum C, Inganäs L, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: A Swedish prospective screening study in 39,821 newborns. BMJ 2009;338:a3037.
  • 10 Andrea J. Implications of using pulse oximetry to screen for critical congenital heart disease in newborns. Nurs Womens Health 2015;19:314-23.
  • 11 Hom LA, Martin GR. U.S. international efforts on critical congenital heart disease screening: Can we have a uniform recommendation for Europe? Early Hum Dev 2014;90 Suppl 2:S11-4.
  • 12 de-Wahl Granelli A, Meberg A, Ojala T, Steensberg J, Oskarsson G, Mellander M. Nordic pulse oximetry screening - implementation status and proposal for uniform guidelines. Acta Paediatr 2014;103:1136-42.
  • 13 Zhao QM, Ma XJ, Ge XL, Liu F, Yan WL, Wu L, et al. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: A prospective study. Lancet 2014;384:747-54.
  • 14 Dawson JA, Davis PG, O′Donnell CP, Kamlin CO, Morley CJ. Pulse oximetry for monitoring infants in the delivery room: A review. Arch Dis Child Fetal Neonatal Ed 2007;92:F4-7.
  • 15 Narayen IC, Blom NA, Ewer AK, Vento M, Manzoni P, Te Pas AB. Aspects of pulse oximetry screening for critical congenital heart defects: When, how and why? Arch Dis Child Fetal Neonatal Ed 2016;101:F162-7.
  • 16 Bhola K, Kluckow M, Evans N. Post-implementation review of pulse oximetry screening of well newborns in an Australian tertiary maternity hospital. J Paediatr Child Health 2014;50:920-5.
  • 17 Manja V, Mathew B, Carrion V, Lakshminrusimha S. Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit. J Perinatol 2015;35:67-71.
  • 18 Lhost JJ, Goetz EM, Belling JD, van Roojen WM, Spicer G, Hokanson JS. Pulse oximetry screening for critical congenital heart disease in planned out-of-hospital births. J Pediatr 2014;165:485-9.
  • 19 Cawsey MJ, Noble S, Cross-Sudworth F, Ewer AK. Feasibility of pulse oximetry screening for critical congenital heart defects in homebirths. Arch Dis Child Fetal Neonatal Ed 2016. pii: Fetalneonatal-2015-309936.
  • 20 Bruno CJ, Havranek T. Screening for critical congenital heart disease in newborns. Adv Pediatr 2015;62:211-26.
  • 21 Peterson C, Grosse SD, Glidewell J, Garg LF, Van Naarden Braun K, Knapp MM, et al. A public health economic assessment of hospitals′ cost to screen newborns for critical congenital heart disease. Public Health Rep 2014;129:86-93.
  • 22 Zuppa AA, Riccardi R, Catenazzi P, D′Andrea V, Cavani M, D′Antuono A, et al. Clinical examination and pulse oximetry as screening for congenital heart disease in low-risk newborn. J Matern Fetal Neonatal Med 2015;28:7-11.
  • 23 Wright J, Kohn M, Niermeyer S, Rausch CM. Feasibility of critical congenital heart disease newborn screening at moderate altitude. Pediatrics 2014;133:e561-9.
  • 24 Pattishall AE, Spector ND, McPeak KE. Important considerations for the newborn: Access to postdischarge newborn care, pulse oximetry screening for congenital heart disease, and circumcision. Curr Opin Pediatr 2014;26:734-40.
  • 25 Hilton-Kamm D, Sklansky M, Chang RK. How not to tell parents about their child′s new diagnosis of congenital heart disease: An Internet survey of 841 parents. Pediatr Cardiol 2014;35:239-52.
  • 26 Powell R, Pattison HM, Bhoyar A, Furmston AT, Middleton LJ, Daniels JP, et al. Pulse oximetry screening for congenital heart defects in newborn infants: An evaluation of acceptability to mothers. Arch Dis Child Fetal Neonatal Ed 2013;98:F59-63.